A new study has found that “blood levels of tetrahydrocannabinol do not correlate well with the level of impairment”, and heavy marijuana use doesn’t consistently lead to “cognitive and psychomotor impairment”. “Marijuana is the most widely consumed illicit substance in the United States, and an increasing number of states have legalized it for both medicinal …
According to a study of nearly 3,000 people, cannabis seems to be a safe, effective and well tolerated palliative treatment for cancer. The study was published in the European Journal of Internal Medicine, and published online by the U.S. National Institute of Health. The aim of the study “is to characterize the epidemiology of cancer patients receiving …
According to a new study published by the journal Cannabis and Cannabinoids Research, and published online by the National Institute of Health, topically-applied cannabinoids are effective in reducing corneal hyperalgesia (defined as a state of nociceptive sensitization caused by exposure to opioids) and inflammation. “Corneal injury can result in dysfunction of corneal nociceptive signaling and corneal …
Cannabinoids hold potential therapeutic use in alcohol-related problems, according to a new study being published in the journal Alcohol, and epublished ahead of print by the U.S. National Institute of Health. “Case reports and observational studies suggest that the use of Cannabis sp. mitigates problematic ethanol consumption in humans”, states the study’s abstract. “Here, we …
According to a new study, Δ9-tetrahydrocannabinol acid (THCA) has potent neuroprotective activity which may help treat Huntington´s Disease and other neurodegenerative and neuroinflammatory diseases. “Phytocannabinoids are produced in Cannabis sativa L. in acidic form and are decarboxylated upon heating, processing, and storage”, states the abstract of the study, published by the British Journal of Pharmacology …
The statewide legalization of medical marijuana is associated with a reduction in hospitalization from opioids, according to a new study. The study, conducted at the University of California, was published by the journal Drug and Alcohol Dependency and the National Institute of Health. Researchers assessed the association between medical cannabis laws and hospitalizations related to …
The oral administration of Δ9-tetrahydrocannabinol (THC) may treat both spasticity and pain associated with multiple sclerosis. This is according to a study being published by the journal Clinical Therapeutics, and e-published ahead of print by the U.S. National Institute of Health. According to the Mayo Clinic, multiple sclerosis (MS) is a “disease in which the …
Activation of the cannabinoid 2 receptor – done naturally through the consumption of cannabis and cannabinoids – may be a potential treatment option for insulin resistance and obesity-related diabetes. This is according to new research out of the Institute of Biomedical Engineering at the Chinese Academy of Medical Science; the study was study published in …
Cannabinoids may provide a treatment option for chronic inflammation, according to a new study published in the FASEB Journal, and published online by the U.S. National Institute of Health. “Cannabinoids apparently act on inflammation through mechanisms different from those of agents such as nonsteroidal anti-inflammatory drugs (NSAIDs)”, states the study’s abstract. “As a class, the …
Cannabinoids enhance tissue engineering strategies aimed at cartilage repair through a dual function approach, according to a new study published in the journal Pharmaceuticals. The study was published online by the National Institute of Health. “This review discusses the role of the cannabinoid system in cartilage tissue and endeavors to establish if targeting the cannabinoid …
Follow Us!